- Anniversary/History
- Membership
- Publications
- Resources
- Education
- Events
- Outreach
- Careers
- About
- For Pain Patients and Professionals
Papers: 3 Sep 2022 - 9 Sep 2022
Pharmacology/Drug Development
2022 Sep 07
Expert Opin Ther Targets
– Dysfunction at various levels of the somatosensory system can lead to ocular surface pain with a neuropathic component. Compared to nociceptive pain (pain due to a noxious stimulus at the ocular surface), neuropathic pain tends to be more chronic and refractory to therapies, making it an important source of morbidity in the population. An understanding of the options available for neuropathic ocular surface pain, including new and emerging therapies, is thus an important topic.